drugset / Trial / NCT06951828

A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P43 in Healthy Male Subjects

NCT06951828

Phase 1 Completed 162 enrolled Celltrion
RandomizedParallel-groupOpen-labelOther

Summary

This is phase 1 study to Compare the Pharmacokinetics, Safety and Immunogenicity of the Auto-injector and Pre-filled syringe of CT-P43 in Healthy Male Subjects.

Timeline

Start
2025-05-30
Primary completion
2025-11-26
Completion
2025-12-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator CT-P43 Protein / enzyme biologic 45 mg Subcutaneous

Indications

No indication recorded.